EGFR and non-small cell lung carcinoma: Given that EGFR mutation or ALK fusion may alter the PD-L1 expression, we used two NSCLC cell lines, including NCI-H460 cells and NCI-H1975 cells, the latter characterized by EGFR-T790 mutation.